Maezawa Kasei Industries Co., Ltd.
Maezawa Kasei Industries Co., Ltd. (7925.T) Financial Performance & Income Statement Overview
Review Maezawa Kasei Industries Co., Ltd. (7925.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Maezawa Kasei Industries Co., Ltd. (7925.T) Income Statement & Financial Overview
View the income breakdown for Maezawa Kasei Industries Co., Ltd. 7925.T across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $6.32B | $6.22B | $5.96B | $5.66B |
Cost of Revenue | $4.10B | $3.88B | $3.79B | $3.63B |
Gross Profit | $2.22B | $2.35B | $2.17B | $2.04B |
Gross Profit Ratio | $0.35 | $0.38 | $0.36 | $0.36 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.67B | $1.75B | $1.54B | $1.65B |
Operating Expenses | $1.67B | $1.74B | $1.54B | $1.65B |
Total Costs & Expenses | $5.77B | $5.62B | $5.33B | $5.28B |
Interest Income | $14.00M | $8.00M | $5.00M | $3.00M |
Interest Expense | $2.00M | $0.00 | $1.00M | $1.00M |
Depreciation & Amortization | $273.00M | $259.00M | $255.00M | $242.00M |
EBITDA | $899.00M | $1.004B | $982.00M | $624.00M |
EBITDA Ratio | $0.14 | $0.16 | $0.16 | $0.11 |
Operating Income | $550.00M | $605.00M | $631.00M | $382.00M |
Operating Income Ratio | $0.09 | $0.10 | $0.11 | $0.07 |
Other Income/Expenses (Net) | $70.00M | $143.00M | $88.00M | $151.00M |
Income Before Tax | $620.00M | $748.00M | $719.00M | $533.00M |
Income Before Tax Ratio | $0.10 | $0.12 | $0.12 | $0.09 |
Income Tax Expense | $239.00M | $239.00M | $241.00M | $176.00M |
Net Income | $374.00M | $507.00M | $476.00M | $357.00M |
Net Income Ratio | $0.06 | $0.08 | $0.08 | $0.06 |
EPS | $25.20 | $34.23 | $32.08 | $23.99 |
Diluted EPS | $25.20 | $34.23 | $32.08 | $23.99 |
Weighted Avg Shares Outstanding | $14.84M | $14.84M | $14.84M | $14.84M |
Weighted Avg Shares Outstanding (Diluted) | $14.84M | $14.84M | $14.84M | $14.84M |
Over the past four quarters, Maezawa Kasei Industries Co., Ltd. demonstrated steady revenue growth, increasing from $5.66B in Q1 2024 to $6.32B in Q4 2024. Operating income reached $550.00M in Q4 2024, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $899.00M, reflecting operational efficiency. Net income dropped to $374.00M, with EPS at $25.20. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan